Food+Tech Connect Cultivated Chicken Receives USDA Approval Cultivated Chicken Receives USDA Approval, Kava IPO Raises $318M + more

Image Credits: green queen

Every week we track business, tech and investment trends in CPG, retail, restaurants, agriculture, cooking and health so you don’t have to. Here are some of this week’s top headlines.

In a significant milestone for the cultured meat industry, California’s Upside Foods and Eat Just have both received USDA label approval. Meanwhile, Kava’s recent initial public offering beat expectations by raising an impressive $318 million.

In other news, we just wrapped the first season of our podcast in partnership with AgFunder: New Food Order, a nuanced investigation into the business of tackling our climate and social crises through food and agriculture. Read all about why we launched the podcast, And be sure to subscribe and share!

The production of our newsletter takes a lot of time and resources. Make a one time or monthly contribution to help us keep it going. Whether it’s $5 or $500, every bit helps and shows us that you value our work.

California’s Upside Foods earned USDA label approval for its cultured meat just days after Eat Just earned a similar clearance for its farmed chicken, bringing cell-based meat one step closer to American plates.

Cava’s initial public offering, at $22 per share, exceeded the expected $17 to $19 per share, which may encourage other restaurants to pursue IPOs.

Balance is reportedly asking the court to auction off the greenhouse to meet the $66m outstanding.

A growing number of states are considering or have passed legislative wording to ban “foreign adversaries” and foreign entities — especially China — from purchasing agricultural land.

Build-to-order, single capsule Fluor Multi-V recently became available to healthcare practitioners through Sun Genomics’ clinical program, Fluor Clinical.

The company is set to receive $132.5m in Chapter 11 financing. Instapots quickly reached saturation and were outcompeted by better-looking products in new categories at similar or lower prices.

Climax scientists have discovered an alternative approach by identifying an abundant and naturally occurring plant protein capable of imparting true melt and stretch to plant-based cheeses.

With the transaction close, the meal kit company plans more layoffs and has paid down its debt as it moves toward an asset-light model focused on profitability.

The James Beard Awards – the Oscars of the food world – is back with a new process to weed out nominees with problematic pasts.

Consumer advocates say Bunge’s agreement to buy Vitera could drive up prices, while Bunge says the companies do not overlap.

Image Credits: green queen

Every week we track business, tech and investment trends in CPG, retail, restaurants, agriculture, cooking and health so you don’t have to. Here are some of this week’s top headlines.

In a significant milestone for the cultured meat industry, California’s Upside Foods and Eat Just have both received USDA label approval. Meanwhile, Kava’s recent initial public offering beat expectations by raising an impressive $318 million.

In other news, we just wrapped the first season of our podcast in partnership with AgFunder: New Food Order, a nuanced investigation into the business of tackling our climate and social crises through food and agriculture. Read all about why we launched the podcast, And be sure to subscribe and share!

The production of our newsletter takes a lot of time and resources. Make a one time or monthly contribution to help us keep it going. Whether it’s $5 or $500, every bit helps and shows us that you value our work.

California’s Upside Foods earned USDA label approval for its cultured meat just days after Eat Just earned a similar clearance for its farmed chicken, bringing cell-based meat one step closer to American plates.

Cava’s initial public offering, at $22 per share, exceeded the expected $17 to $19 per share, which may encourage other restaurants to pursue IPOs.

Balance is reportedly asking the court to auction off the greenhouse to meet the $66m outstanding.

A growing number of states are considering or have passed legislative wording to ban “foreign adversaries” and foreign entities — especially China — from purchasing agricultural land.

Build-to-order, single capsule Fluor Multi-V recently became available to healthcare practitioners through Sun Genomics’ clinical program, Fluor Clinical.

The company is set to receive $132.5m in Chapter 11 financing. Instapots quickly reached saturation and were outcompeted by better-looking products in new categories at similar or lower prices.

Climax scientists have discovered an alternative approach by identifying an abundant and naturally occurring plant protein capable of imparting true melt and stretch to plant-based cheeses.

With the transaction close, the meal kit company plans more layoffs and has paid down its debt as it moves toward an asset-light model focused on profitability.

The James Beard Awards – the Oscars of the food world – is back with a new process to weed out nominees with problematic pasts.

Consumer advocates say Bunge’s agreement to buy Vitera could drive up prices, while Bunge says the companies do not overlap.